What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 798, doi. 10.1007/s11864-024-01218-z
- By:
- Publication type:
- Article
Works matching IS 15272729 AND DT 2024 AND VI 25 AND IP 6
Results: 8
1
2
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 752, doi. 10.1007/s11864-024-01217-0
- By:
- Publication type:
- Article
3
Correction to: Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
4
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 813, doi. 10.1007/s11864-024-01209-0
- By:
- Publication type:
- Article
5
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 784, doi. 10.1007/s11864-024-01206-3
- By:
- Publication type:
- Article
6
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 719, doi. 10.1007/s11864-024-01202-7
- By:
- Publication type:
- Article
7
Post-Radiotherapy Dysphagia in Head and Neck Cancer: Current Management by Speech-Language Pathologists.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 703, doi. 10.1007/s11864-024-01198-0
- By:
- Publication type:
- Article
8
Genetic Predisposition to Sarcoma: What Should Clinicians Know?
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 6, p. 769, doi. 10.1007/s11864-024-01192-6
- By:
- Publication type:
- Article